DrugDashboards

Market view

florbetaben f 18 · Injection, Solution

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for florbetaben f 18, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • NeuraceqAug 5, 2026
    Mfr exited
    Lantheus Biosciences Ltd., a Lantheus Company · florbetaben f 18
  • NeuraceqJul 29, 2026
    Mfr entered
    Lantheus Biosciences Ltd., a Lantheus company · florbetaben f 18
  • NeuraceqJul 29, 2026
    Product update
    labeler name: Lantheus Biosciences Ltd., a Lantheus Company → Lantheus Biosciences Ltd., a Lantheus company

Same drug class

Other molecules FDA puts in Radioactive Diagnostic Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Florbetaben f 18 in shortage right now?
No. FDA does not currently list Florbetaben f 18 in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Florbetaben f 18?
1 company has marketed Florbetaben f 18 in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.